Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00970671 · ClinicalTrials.gov registry record · NA

Treatment of Surgical Scars Using the Pulsed Dye Laser

A NA study of Scar and Laser Therapy, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT00970671: Completed NA study of Scar and Laser Therapy, sponsored by University of California, San Diego.

NCT00970671 is a NA study of Scar and Laser Therapy that has completed, run by University of California, San Diego. The registered enrollment target is 28 participants, below the 47-participant average among 15 other Scar trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00970671, a NA study of Scar and Laser Therapy, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether treatment of fresh surgical scars with a pulsed dye laser using purpura-inducing settings will improve clinical appearance better than one using non-purpura-inducing settings or no treatment.

Conditions Studied

Interventions

  • OTHER No treatment
  • OTHER Laser treatment with Purpuric settings
  • OTHER Laser treatment with Nonpurpuric settings

Study Locations (1)

California

  • UCSD Perlman Ambulatory Center - Dermatology clinic - La Jolla

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2009-09
Est. Completion 2010-12
Phase NA
University of California, San Diego

775 total trials

What the finished NCT00970671 record still lists

NCT00970671 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 47-participant average among 15 other Scar trials with a reported enrollment target (40% lower).

The record links to 2 conditions, with Scar appearing as the primary indexed condition, and to 3 interventions - of which No treatment is the first listed.

NCT00970671 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00970671 about?

NCT00970671 is a clinical study titled "Treatment of Surgical Scars Using the Pulsed Dye Laser". The purpose of this study is to determine whether treatment of fresh surgical scars with a pulsed dye laser using purpura-inducing settings will improve clinical appearance better than one using non-purpura-inducing settings or no treatment.

What is the current status of trial NCT00970671?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2009-09. Estimated completion is 2010-12.

What conditions does trial NCT00970671 study?

This clinical trial studies the following conditions: Scar, Laser Therapy.

What interventions are being tested in trial NCT00970671?

The interventions under investigation include: No treatment (OTHER), Laser treatment with Purpuric settings (OTHER), Laser treatment with Nonpurpuric settings (OTHER).

Who is sponsoring clinical trial NCT00970671?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00970671 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Scar

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00970671's enrollment target sits among peer trials

28 12th of 15 higher than 4 of 15 other Scar trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Scar trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00970671, the US trial registry maintained by the National Library of Medicine. NCT00970671 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.